ZoomInfo Technologies has experienced a significant increase in its shares following an upgrade from BofA Global Research analyst Koji Ikeda.
In his research note, Ikeda raised his rating on the stock from Neutral to Buy and increased the price target to $25, up from $20. As a result, ZoomInfo shares have soared by 7.6% to $17, potentially providing an impressive gain of over 30%.
Ikeda praises ZoomInfo as a leading sales enablement platform that empowers customers to enhance their customer acquisition strategies, driving higher efficiencies. During the past year, the company's shares have declined by 39%, largely due to concerns over its growth rate. However, Ikeda anticipates a turnaround, projecting a return to high single-digit growth with the aid of a revamped management team.
Moreover, Ikeda highlights the introduction of new AI-powered versions of ZoomInfo's service, which are expected to enhance monetization opportunities. Additionally, he believes the conclusion of the Federal Reserve's credit-tightening cycle will have a positive impact on mid-cap stocks like ZoomInfo.
Furthermore, the analyst emphasizes that ZoomInfo possesses a "strong and differentiated" brand, while its stock is currently trading at a valuation that is 50% lower than its peers in the software industry.
Polaris Set to Report Fourth-Quarter Results
Related Articles
![U.K. House Prices Experience Largest Decline in 14 Years](https://www.signalsforex.net/img/0888b08e-b978-43c0-bdb4-4db1785eb1d5/news-article-3.jpeg?fm=jpg&q=80&fit=max&crop=1440%2C1080%2C240%2C0)
U.K. House Prices Experience Largest Decline in 14 Years
In July, U.K. house prices saw the biggest decline in 14 years, as rising interest rates and mortgage payments impact the housing market. Transactions also decr...
![Stock Futures in the U.S.](https://www.signalsforex.net/img/0888b08e-b978-43c0-bdb4-4db1785eb1d5/news-article-3.jpeg?fm=jpg&q=80&fit=max&crop=1440%2C1080%2C240%2C0)
Stock Futures in the U.S.
Futures for the S&P 500 and the Dow Jones Industrial Average point to a positive start. European stocks display mixed performance while Asian stocks show positi...
![Exciting Times for Eli Lilly](https://www.signalsforex.net/img/0888b08e-b978-43c0-bdb4-4db1785eb1d5/news-article-3.jpeg?fm=jpg&q=80&fit=max&crop=1440%2C1080%2C240%2C0)
Exciting Times for Eli Lilly
Shares of Eli Lilly have surged as the company's stock stands out in the healthcare sector. With groundbreaking treatments like Mounjaro and the anticipated lau...